Stereotaxis (STXS) Peer Comparison

$0.97

$-0.95 (-49.46%)

As on 28-Oct-2026 16:00EDT

Market cap

$100 Mln

Revenue (TTM)

$30 Mln

P/E Ratio

--

P/B Ratio

11.5

Div. Yield

0 %

Edit

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Market cap ($ Mln)	100	12,800	11,233	11,600	10,422
Revenue ($ Mln)	30	1,505	785	6,561	613
Net Profit ($ Mln)	-22.32	160.59	41.54	-578.00	-188.05
Net Margin (%)	-74.24	10.67	5.29	-8.81	-30.68
RoE (%)	-123.34	10.86	1.97	-10.33	-28.10
Price to Earnings	--	79.84	242.37	--	--
Price-To-Book	11.46	8.22	4.41	1.77	13.27

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Operating Revenue	30.07	1,504.87	785.10	6,561.10	612.84
Cost of Revenue	13.36	483.98	384.30	4,473.00	127.96
Gross Profit	17.07	942.44	347.62	2,139.40	393.22
Operating Expenses	38.66	833.56	335.50	2,373.70	565.37
Operating Profit (EBIT)	-21.96	187.34	65.30	-285.60	-80.49
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-22.32	203.83	52.15	-472.00	-192.83
Provision for Tax	0.00	43.24	10.61	106.00	-4.79
Profit after Tax (Net Income)	-22.32	160.59	41.54	-578.00	-188.05
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	93.19	0.00	0.00	0.00

Liabilities ($ Mln)

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Shareholder's Funds	17.48	1,530.77	2,112.03	5,630.20	682.49
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	11.31	210.18	705.49	4,583.70	135.71
Current Liabilities	26.80	233.78	132.66	1,382.00	102.33
Total Liabilities	52.25	1,826.52	2,949.70	11,794.70	893.49

Assets ($ Mln)

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Non-Current Assets	17.60	630.60	1,749.63	9,133.70	404.74
Current Assets	37.99	1,344.12	1,200.55	2,462.20	515.78
Total Assets	52.25	1,826.52	2,949.70	11,794.70	893.49
Total Debt*	5.17	212.71	690.94	3,697.80	102.84
Net Current Assets	11.19	1,110.35	1,067.90	1,080.20	413.45

Cashflow ($ Mln)

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Cash From Operating Activities	-13.69	238.66	117.42	623.80	-46.34
Cash Flow from Investing Activities	-0.09	-404.59	-298.47	-130.50	-77.61
Cash from Financing Activities	14.76	26.53	-15.21	-409.40	11.89
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
ROCE (%)	-104.07	11.76	1.79	-5.43	-22.53
ROE (%)	-123.34	10.86	1.97	-10.33	-28.10
ROA (%)	-30.94	7.95	1.36	-4.08	-18.00
EBIT Margin (%)	-74.24	13.63	9.87	-4.47	-30.58
Net Margin (%)	-74.24	10.67	5.29	-8.81	-30.68
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Revenue Growth (%)	-5.47	17.55	16.49	-1.57	41.55
EBIT Growth (%)	4.41	17.49	920.78	-129.16	-116.42
Net Profit Growth (%)	4.41	8.72	400.42	-184.08	-102.66
EPS Growth (%)	13.69	8.12	394.30	-184.11	-96.88
Book Value Growth (%)	127.35	17.33	2.16	-9.82	-12.65

Valuation Ratios

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Price / Earnings	-10.20	68.93	189.42	-14.68	-34.59
Price / Book Value	11.79	8.58	4.40	1.40	9.90
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-10.59	53.25	50.32	81.94	-43.50
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Debt to Equity	0.00	0.00	0.26	0.65	0.00
Short term debt to equity ratio	0.04	0.01	0.01	0.01	0.00
Current Ratio	1.42	5.75	9.05	1.78	5.04
Quick Ratio	0.95	3.86	7.64	1.18	4.46
Interest Coverage	--	157.91	1.92	-1.64	-38.31

Operating Efficiency Ratios

	Stereotaxis (STXS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Debtors to sales (%)	46.11	12.65	20.09	17.36	22.67
Asset Turnover	0.42	0.74	0.26	0.46	0.59
Receivable days	78.89	46.54	72.41	58.79	60.95
Inventory Days	213.55	331.92	146.53	64.13	193.84
Payable days	124.52	26.16	29.05	58.13	60.19
Cash Conversion Cycle	167.93	352.30	189.88	64.79	194.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly